These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10728578)

  • 21. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. 5-6 May 1998, Strasbourg, France.
    Castle P; Robertson JS
    Biologicals; 1998 Dec; 26(4):365-8. PubMed ID: 10403041
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood substitutes as pharmacotherapies in clinical practice.
    Jahr JS; Walker V; Manoochehri K
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current issues in transfusion medicine.
    Goodnough L
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):614-6. PubMed ID: 16167045
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychiatric expert witnesses in the new millennium.
    Gutheil TG
    Psychiatr Clin North Am; 2006 Sep; 29(3):823-32, ix. PubMed ID: 16904514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming blood shortages: red blood cell and platelet substitutes and membrane modifications.
    Davey RJ
    Curr Hematol Rep; 2004 Mar; 3(2):92-6. PubMed ID: 14965484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panel discussion: perspectives in aging research in the new millennium.
    Park SC
    Ann N Y Acad Sci; 2001 Apr; 928():336-43. PubMed ID: 11795525
    [No Abstract]   [Full Text] [Related]  

  • 29. [Synthetic hemoglobin in heart surgery: What can we expect of them?].
    Barón JF
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):481. PubMed ID: 11792306
    [No Abstract]   [Full Text] [Related]  

  • 30. Red cell substitutes.
    Winslow RM
    Semin Hematol; 2007 Jan; 44(1):51-9. PubMed ID: 17198847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of researches in the development of blood tissue engineering product].
    Li F; Wang J; Yang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):972-5. PubMed ID: 18788321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood substitutes in 2010 [ 1 ].
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Dec; 38(6):295-6. PubMed ID: 21073278
    [No Abstract]   [Full Text] [Related]  

  • 34. Overcoming the limitations of artificial clinical specimens: linkage to performance of patients' specimens.
    Powers DM
    Clin Chem; 1995 Dec; 41(12 Pt 1):1689-92. PubMed ID: 7497606
    [No Abstract]   [Full Text] [Related]  

  • 35. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice?
    Lamy M; Deby-Dupont G
    Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348
    [No Abstract]   [Full Text] [Related]  

  • 36. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
    Winslow RM
    Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood substitutes based on nanobiotechnology.
    Chang TM
    Trends Biotechnol; 2006 Aug; 24(8):372-7. PubMed ID: 16815577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated quantitation of hemoglobin-based blood substitutes in whole blood samples.
    Kunicka J; Malin M; Zelmanovic D; Katzenberg M; Canfield W; Shapiro P; Mohandas N
    Am J Clin Pathol; 2001 Dec; 116(6):913-9. PubMed ID: 11764082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new millennium in cognitive neuropsychology research: the era of individual differences?
    O'Boyle MW
    Brain Cogn; 2000 Feb; 42(1):135-8. PubMed ID: 10739620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.